Search Results 2101-2110 of 16027 for Epilepsy (Partial Onset)

  1. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    ... duration of treatment with study drug plus 5 months after the last dose of ... Sexually active fertile men who are sexually active with WOCBP must agree to follow ...

  2. Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer - Mayo Clinic

    ... duration of the study, or is not in the best interest of the patient to participate, in the opinion of the treating Investigator, including, but not limited to:.

  3. Pilot Study of Care at Home for Monitoring Brain Tumor Patients - Mayo Clinic

    ... duration of the study including undergoing treatment, and attending scheduled visits, and examinations * The following laboratory values obtained ≤ 30 days ...

  4. Ustekinumab-kfce (intravenous route, subcutaneous route) - Mayo Clinic

    Check with your doctor if you have headache, seizures, confusion, or blurred vision or other visual problems. These may be symptoms of a rare and serious ...

  5. Publications - Rebecca L. King, M.D. - Mayo Clinic

    Assessment of fixed-duration therapies for treatment-naive Waldenstrom macroglobulinemia. ... Partial response or better at six months is prognostic of superior ...

  6. HELP-HY: Health Education and sLeep Program in HYpertension - Mayo Clinic

    - Habitual sleep duration <7 hours and voluntary prolongation of sleep when circumstances allow - Presence of prehypertension, Stage 1 hypertension, or ...

  7. The PEERLESS II Study - Mayo Clinic

    Symptom onset within 14 days of confirmed PE diagnosis 6. Willing and able to provide informed consent. Exclusion Criteria: 1. Unable to be anticoagulated ...

  8. First aid - Mayo Clinic

    First aid information from Mayo Clinic for use during a medical emergency.

  9. ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) - Mayo Clinic

    The once-nightly dosing regimen may also provide enhanced convenience and compliance. In a previous clinical study, ADS-5102 met its primary endpoint; LID was ...

  10. A Study to Evaluate the Combination of Selinexor with Pomalidomide and Dexamethasone +/- Carfilzomib to Treat Patients with Refractory Multiple Myeloma - Mayo Clinic

    - Willingness to use fixed-duration therapy (up to 18 cycles) for relapsed refractory ... Prothrombin time (PT)/international normalized ratio (INR)/activated ...